Same Diagnosis, Different Patient
Why two people with the same condition can need different plans, and how that idea shapes cellular medicine research for digestive, joint and lower back conditions.
- Stem Cells
- 2 min
08/01/2026
One Label, Many Stories
A diagnosis is a starting point. Two people told they have rheumatoid arthritis, or Crohn’s disease, may differ in age, severity, other illnesses and response to past treatment. A plan that suits one may do little for the other. Personalized medicine takes those differences seriously, and regenerative medicine has adopted the same principle.
Digestive Inflammation
Researchers are exploring how cell therapy may support tissue healing and immune balance in chronic digestive inflammation. Because these conditions vary widely in where they affect the gut and how severe they become, individual assessment is central to any discussion of treatment.
Some patients have mild, localized disease, while others live with more extensive inflammation and frequent flares.
Inflammatory Joint Conditions
In autoimmune joint disease, studies are looking at whether cellular therapies may contribute to healthier joints and better physical function over time. Outcomes reported so far differ between patients, which supports careful selection and honest expectations.
Persistent Lower Back Pain
Ongoing studies are also evaluating cellular approaches for long-term lower back conditions. Some people come to this research after conventional treatment has not given them the relief they hoped for, and they want to understand every option before deciding.
A physician can help them sort the research that applies to their situation from the research that does not.
Tailoring in Practice
At Regeneration Clinic, tailoring starts with a medical evaluation. Our physicians review records and imaging, discuss goals and decide with the patient whether treatment is appropriate. When it is, we use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. The plan, the expectations and the follow-up are then set for that person, and no two plans look exactly alike.
08/01/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






